2030년까지 북미 마이크로바이옴 치료제 시장 예측 – 유형(치료제 및 절차), 애플리케이션(대사 장애 및 비만, C. 난치성 감염, 염증성 장 질환 및 기타) 및 최종 사용자(병원 및 진료소, 외래 수술)별 지역 분석 센터, 홈케어 및 기타)

북미 마이크로바이옴 치료제 시장은 2022년에 1억 6,164만 달러로 평가되었으며, 2030년에는 3억 4,299만 달러에 이를 것으로 예상됩니다. 2022년부터 2030년까지 9.9%의 연평균 성장률(CAGR)을 기록할 것으로 추정됩니다. 미생물군집 발견 파이프라인을 개선하기 위한 자금 유입으로 북미 미생물군집 치료제 시장 조사에 따르면 미생물군집의 불균형이나 혼란이 염증성 장 질환과 같은 다양한 상태에 기여할 수 있는 것으로 나타났습니다. 비만, 정신 건강 장애 등이 있습니다. 전반적인 건강에서 미생물군집의 역할에 대한 인식은 미생물군집을 표적으로 삼고 조절하는 치료법 개발에 상당한 관심을 불러일으켰습니다. 또한 기술과 연구 도구의 발전으로 미생물군집을 연구하고 조작하는 것이 더 쉬워졌습니다. 차세대 염기서열 분석 및 메타게놈 분석을 통해 미생물 군집과 그 기능에 대한 더 깊은 이해가 가능해졌습니다. 지식의 증가로 표적 치료법 개발의 새로운 가능성이 열렸습니다. 미국 식품의약국(FDA)과 같은 규제 기관도 마이크로바이옴 치료제 개발을 지원하겠다는 의지를 보여왔습니다. FDA는 FMT에 대한 지침을 확립했으며 안전성과 효능을 보장하는 규제 경로를 통해 해당 분야를 발전시키는 데 관심을 표명했습니다. 이러한 모든 요인들이 결합되어 마이크로바이옴 치료 분야에 종사하는 기업들에게 유리한 투자 환경을 조성했습니다. 강력한 임상 증거가 확보됨에 따라 투자자들은 마이크로바이옴 조절제 회사에 주목하기 시작했습니다. 강화된 자금은 기업이 높은 개발 및 생산 비용과 관련된 과제를 극복하고 궁극적으로 해당 분야를 발전시키는 데 필요한 자원을 제공합니다. 북미 마이크로바이옴 치료제 시장 개요 건강을 유지하고 질병을 예방하는 데 있어서 인간 마이크로바이옴의 중요성에 대한 이해가 높아지면서 미국 연구자들은 다양한 질환을 치료하기 위한 유망한 접근 방식으로 마이크로바이옴 기반 개입을 탐구하게 되었습니다. 또한, 북미 마이크로바이옴 치료 시장에서 이 나라의 지배력은 주로 혁신적인 치료법 개발을 선호하는 잘 발달된 연구 인프라에 기인합니다. 또한, 비만 및 염증성 장 질환과 같은 만성 질환의 유병률 증가로 인해 수요가 창출되었습니다. 혁신적인 치료법을 위해 마이크로바이옴 치료제 개발에 박차를 가하고 있습니다. 유전자 염기서열 분석 및 생물정보학의 기술적 발전으로 미생물군집에 대한 연구 및 변경이 가능해지고 개인화된 미생물군집 기반 개입 개발이 촉진됩니다. 맞춤 의학을 향한 추세는 맞춤형 마이크로바이옴 치료법과 잘 일치합니다. 학계, 산업계, 정부 기관 간의 협력도 연구 개발 노력을 촉진하여 과학적 발견을 상용 제품으로 전환하는 것을 가속화하고 있습니다. 규제 기관이 미생물군유전체 치료제의 잠재력을 인식하고 개발 및 승인에 대한 지침을 제공함에 따라 해당 분야에 대한 규제 지원 및 투자는 시장 성장에 더욱 기여합니다. 북미 마이크로바이옴 치료제 시장 수익 및 2030년 예측(미화 백만 달러) 북미 마이크로바이옴 치료제 시장 세분화 북미 마이크로바이옴 치료제 시장은 유형, 응용 프로그램, 최종 사용자 및 국가를 기준으로 분류됩니다. 유형에 따라 북미 마이크로바이옴 치료제 시장은 치료제와 시술로 구분됩니다. 시술 부문은 2022년에 더 큰 점유율을 차지했습니다. 치료 부문은 대변 미생물 이식(FMT), 프리바이오틱스 및 프로바이오틱스 등으로 더욱 세분화됩니다. 적용에 따라 북미 마이크로바이옴 치료제 시장은 대사 장애 및 비만, C. difficile 감염, 염증성 장 질환 등으로 분류됩니다. C. difficile 감염 부문은 2022년에 가장 큰 점유율을 차지했습니다. 최종 사용자 기준으로 북미 마이크로바이옴 치료제 시장은 병원 및 진료소, 외래 수술 센터, 홈케어 등입니다. 병원 및 진료소 부문은 2022년에 가장 큰 점유율을 차지했습니다. 국가별로 북미 마이크로바이옴 치료제 시장은 미국, 캐나다 및 멕시코로 분류됩니다. 미국은 2022년 북미 마이크로바이옴 치료제 시장을 장악했습니다. AOBiome Therapeutics Inc, Ferring Holdings SA, Finch Therapeutics Group Inc, Pendulum Therapeutics Inc 및 Seres Therapeutics Inc는 북미 마이크로바이옴 치료제 시장에서 활동하는 선도적인 회사 중 일부입니다.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Microbiome Therapeutics Market Landscape

4.1 Overview

4.2 North America PEST Analysis

5. North America Microbiome Therapeutics Market - Key Industry Dynamics

5.1 North America Microbiome Therapeutics Market - Key Industry Dynamics

5.2 Key Market Drivers

5.2.1 Potential of Gut Microbiota in Maintaining Human Health

5.2.2 Inflow of Funds to Ameliorate Microbiome Discovery Pipeline

5.3 Key Market Restraints

5.3.1 High Cost of Development and Production

5.4 Key Market Opportunities

5.4.1 Increasing R&D to Gain Better Understanding of Human Microbiome

5.5 Key Future Trends

5.5.1 Technological Advancement in Human Microbiome Therapeutics

5.6 Impact of Drivers and Restraints:

6. Microbiome Therapeutics Market - North America Market Analysis

7. North America Microbiome Therapeutics Market Analysis - Type

7.1 Therapeutics

7.1.1 Overview

7.1.2 Therapeutics Market, Revenue and Forecast to 2030 (US$ Thousand)

7.2 Procedure

7.2.1 Overview

7.2.2 Procedure Market, Revenue and Forecast to 2030 (US$ Thousand)

8. North America Microbiome Therapeutics Market Analysis - Application

8.1 Metabolic Disorder and Obesity

8.1.1 Overview

8.1.2 Metabolic Disorder and Obesity Market, Revenue and Forecast to 2030 (US$ Thousand)

8.2 C. Difficile Infection (CDI)

8.2.1 Overview

8.2.2 C. Difficile Infection (CDI) Market, Revenue and Forecast to 2030 (US$ Thousand)

8.3 Inflammatory Bowel Disease

8.3.1 Overview

8.3.2 Inflammatory Bowel Disease Market, Revenue and Forecast to 2030 (US$ Thousand)

8.4 Others

8.4.1 Overview

8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

9. North America Microbiome Therapeutics Market Analysis - End User

9.1 Hospitals and Clinics

9.1.1 Overview

9.1.2 Hospitals and Clinics Market, Revenue and Forecast to 2030 (US$ Thousand)

9.2 Ambulatory Surgical Centers

9.2.1 Overview

9.2.2 Ambulatory Surgical Centers Market, Revenue and Forecast to 2030 (US$ Thousand)

9.3 Homecare

9.3.1 Overview

9.3.2 Homecare Market, Revenue and Forecast to 2030 (US$ Thousand)

9.4 Others

9.4.1 Overview

9.4.2 Others Market, Revenue and Forecast to 2030 (US$ Thousand)

10. North America Microbiome Therapeutics Market - Country Analysis

10.1 North America Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.1 North America Microbiome Therapeutics Market Revenue and Forecasts and Analysis - By Country

10.1.2 US

10.1.2.1 US: North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.2.2 US: North America Microbiome Therapeutics Market Breakdown by Type

10.1.2.2.1 US North America Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.2.3 US: North America Microbiome Therapeutics Market Breakdown by Application

10.1.2.4 US: North America Microbiome Therapeutics Market Breakdown by End User

10.1.3 Canada

10.1.3.1 Canada: North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.3.2 Canada: North America Microbiome Therapeutics Market Breakdown by Type

10.1.3.2.1 Canada North America Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.3.3 Canada: North America Microbiome Therapeutics Market Breakdown by Application

10.1.3.4 Canada: North America Microbiome Therapeutics Market Breakdown by End User

10.1.4 Mexico

10.1.4.1 Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousands)

10.1.4.2 Mexico: North America Microbiome Therapeutics Market Breakdown by Type

10.1.4.2.1 Mexico: North America Microbiome Therapeutics Market Breakdown by Therapeutics

10.1.4.3 Mexico: North America Microbiome Therapeutics Market Breakdown by Application

10.1.4.4 Mexico: North America Microbiome Therapeutics Market Breakdown by End User

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in North America Microbiome Therapeutics Market

12. Company Profiles

12.1 Ferring Holdings SA

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Vedanta Biosciences Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Finch Therapeutics Group Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Pendulum Therapeutics Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Seres Therapeutics Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 AOBiome Therapeutics Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. North America Microbiome Therapeutics Market Segmentation

Table 2. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - Type

Table 3. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - Therapeutics

Table 4. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - Application

Table 5. North America Microbiome Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand) - End User

Table 6. North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Country

Table 7. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 8. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 9. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 10. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 11. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 12. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 13. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 14. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 15. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Type

Table 16. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Therapeutics

Table 17. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By Application

Table 18. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands) - By End User

Table 19. Recent Growth Strategies in North America Microbiome Therapeutics Market

Table 20. Glossary of Terms, North America Microbiome Therapeutics Market

List of Figures

Figure 1. North America Microbiome Therapeutics Market Segmentation, By Country

Figure 2. North America PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. North America Microbiome Therapeutics Market Revenue (US$ Thousand), 2022 - 2030

Figure 5. North America Microbiome Therapeutics Market Share (%) - Type, 2022 and 2030

Figure 6. Therapeutics Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 7. Procedure Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 8. North America Microbiome Therapeutics Market Share (%) - Application, 2022 and 2030

Figure 9. Metabolic Disorder and Obesity Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 10. C. Difficile Infection (CDI) Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 11. Inflammatory Bowel Disease Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 12. Others Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 13. North America Microbiome Therapeutics Market Share (%) - End User, 2022 and 2030

Figure 14. Hospitals and Clinics Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 15. Ambulatory Surgical Centers Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 16. Homecare Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 17. Others Market Revenue and Forecasts to 2030 (US$ Thousand)

Figure 18. North America Microbiome Therapeutics Market Breakdown by Key Countries - Revenue (2022) (US$ Thousand)

Figure 19. North America Microbiome Therapeutics Market Breakdown by Key Countries, 2022 and 2030 (%)

Figure 20. US: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 21. Canada: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

Figure 22. Mexico: North America Microbiome Therapeutics Market Revenue and Forecasts To 2030 (US$ Thousands)

1. AOBiome Therapeutics Inc

2. Ferring Holdings SA

3. Finch Therapeutics Group Inc

4. Pendulum Therapeutics Inc

5. Seres Therapeutics Inc

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America microbiome therapeutics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in North America microbiome therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth North America market trends and outlook coupled with the factors driving the microbiome therapeutics market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3550

$2840

Site License

$4550

$3640

Enterprise License

$5550

$4440

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Get Free Sample For North America Microbiome Therapeutics Market

WHAT'S INCLUDED IN FULL REPORT